BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

595 related articles for article (PubMed ID: 28246379)

  • 1. The antibiotic resistance crisis, with a focus on the United States.
    Martens E; Demain AL
    J Antibiot (Tokyo); 2017 May; 70(5):520-526. PubMed ID: 28246379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tackling Threats and Future Problems of Multidrug-Resistant Bacteria.
    Medina E; Pieper DH
    Curr Top Microbiol Immunol; 2016; 398():3-33. PubMed ID: 27406189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Designing drugs that overcome antibacterial resistance: where do we stand and what should we do?
    Penchovsky R; Traykovska M
    Expert Opin Drug Discov; 2015 Jun; 10(6):631-50. PubMed ID: 25981754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nature's clarion call of antibacterial resistance: are we listening?
    Theuretzbacher U; Toney JH
    Curr Opin Investig Drugs; 2006 Feb; 7(2):158-66. PubMed ID: 16499286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibiotics Clinical Development and Pipeline.
    Hesterkamp T
    Curr Top Microbiol Immunol; 2016; 398():447-474. PubMed ID: 26162565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of antibiotic use in adult dairy cows on antimicrobial resistance of veterinary and human pathogens: a comprehensive review.
    Oliver SP; Murinda SE; Jayarao BM
    Foodborne Pathog Dis; 2011 Mar; 8(3):337-55. PubMed ID: 21133795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibiotics for emerging pathogens.
    Fischbach MA; Walsh CT
    Science; 2009 Aug; 325(5944):1089-93. PubMed ID: 19713519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibiotic resistance.
    Frieri M; Kumar K; Boutin A
    J Infect Public Health; 2017; 10(4):369-378. PubMed ID: 27616769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospects for new antibiotics: a molecule-centered perspective.
    Walsh CT; Wencewicz TA
    J Antibiot (Tokyo); 2014 Jan; 67(1):7-22. PubMed ID: 23756684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of Emergence of Resistance in Pathogenic Bacteria: Keeping Our Powder Dry, Part 1.
    Drusano GL; Louie A; MacGowan A; Hope W
    Antimicrob Agents Chemother; 2015 Dec; 60(3):1183-93. PubMed ID: 26711759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The antibiotic resistome: challenge and opportunity for therapeutic intervention.
    Martínez JL
    Future Med Chem; 2012 Mar; 4(3):347-59. PubMed ID: 22393941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Future antibiotics scenarios: is the tide starting to turn?
    Theuretzbacher U
    Int J Antimicrob Agents; 2009 Jul; 34(1):15-20. PubMed ID: 19342202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vital Signs: Estimated Effects of a Coordinated Approach for Action to Reduce Antibiotic-Resistant Infections in Health Care Facilities - United States.
    Slayton RB; Toth D; Lee BY; Tanner W; Bartsch SM; Khader K; Wong K; Brown K; McKinnell JA; Ray W; Miller LG; Rubin M; Kim DS; Adler F; Cao C; Avery L; Stone NT; Kallen A; Samore M; Huang SS; Fridkin S; Jernigan JA
    MMWR Morb Mortal Wkly Rep; 2015 Aug; 64(30):826-31. PubMed ID: 26247436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery research: the scientific challenge of finding new antibiotics.
    Livermore DM;
    J Antimicrob Chemother; 2011 Sep; 66(9):1941-4. PubMed ID: 21700626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bacterial genome engineering and synthetic biology: combating pathogens.
    Krishnamurthy M; Moore RT; Rajamani S; Panchal RG
    BMC Microbiol; 2016 Nov; 16(1):258. PubMed ID: 27814687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current and future challenges in the development of antimicrobial agents.
    Rennie RP
    Handb Exp Pharmacol; 2012; (211):45-65. PubMed ID: 23090595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibiotic resistance-the problem intensifies.
    Levy SB
    Adv Drug Deliv Rev; 2005 Jul; 57(10):1446-50. PubMed ID: 15949867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Fosfomycin--its significance for treatment of diseases due to multidrug-resistant bacteria].
    Stock I
    Med Monatsschr Pharm; 2015 Jan; 38(1):4-11. PubMed ID: 26349119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current Technology in the Discovery and Development of Novel Antibacterials.
    Chung PY
    Curr Drug Targets; 2018; 19(7):832-840. PubMed ID: 28891454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of Emergence of Resistance in Pathogenic Bacteria: Keeping Our Powder Dry, Part 2.
    Drusano GL; Hope W; MacGowan A; Louie A
    Antimicrob Agents Chemother; 2015 Dec; 60(3):1194-201. PubMed ID: 26711766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.